nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP1A1—Clobetasol propionate—psoriasis	0.163	0.192	CbGbCtD
Chlorzoxazone—CYP2A6—Methoxsalen—psoriasis	0.1	0.118	CbGbCtD
Chlorzoxazone—CYP1A1—Methoxsalen—psoriasis	0.0855	0.101	CbGbCtD
Chlorzoxazone—CYP1A2—Clobetasol propionate—psoriasis	0.0727	0.0856	CbGbCtD
Chlorzoxazone—CYP1A1—Cholecalciferol—psoriasis	0.0567	0.0667	CbGbCtD
Chlorzoxazone—CYP2A6—Prednisolone—psoriasis	0.0487	0.0573	CbGbCtD
Chlorzoxazone—CYP1A2—Methoxsalen—psoriasis	0.0382	0.045	CbGbCtD
Chlorzoxazone—CYP2D6—Hydroxyurea—psoriasis	0.0344	0.0405	CbGbCtD
Chlorzoxazone—CYP2A6—Dexamethasone—psoriasis	0.0287	0.0338	CbGbCtD
Chlorzoxazone—CYP3A4—Calcitriol—psoriasis	0.0257	0.0303	CbGbCtD
Chlorzoxazone—CYP1A1—Dexamethasone—psoriasis	0.0245	0.0289	CbGbCtD
Chlorzoxazone—CYP2D6—Cholecalciferol—psoriasis	0.0209	0.0245	CbGbCtD
Chlorzoxazone—CYP3A4—Methoxsalen—psoriasis	0.02	0.0236	CbGbCtD
Chlorzoxazone—CYP2E1—Dexamethasone—psoriasis	0.0189	0.0223	CbGbCtD
Chlorzoxazone—CYP2D6—Cyclosporine—psoriasis	0.0137	0.0161	CbGbCtD
Chlorzoxazone—CYP3A4—Cholecalciferol—psoriasis	0.0133	0.0156	CbGbCtD
Chlorzoxazone—CYP3A4—Triamcinolone—psoriasis	0.0115	0.0135	CbGbCtD
Chlorzoxazone—CYP3A4—Mycophenolate mofetil—psoriasis	0.0115	0.0135	CbGbCtD
Chlorzoxazone—CYP3A4—Betamethasone—psoriasis	0.00986	0.0116	CbGbCtD
Chlorzoxazone—CYP3A4—Prednisolone—psoriasis	0.00973	0.0115	CbGbCtD
Chlorzoxazone—CYP3A4—Hydrocortisone—psoriasis	0.00923	0.0109	CbGbCtD
Chlorzoxazone—CYP3A4—Prednisone—psoriasis	0.00919	0.0108	CbGbCtD
Chlorzoxazone—CYP2D6—Dexamethasone—psoriasis	0.00902	0.0106	CbGbCtD
Chlorzoxazone—CYP3A4—Cyclosporine—psoriasis	0.00871	0.0103	CbGbCtD
Chlorzoxazone—CYP3A4—Dexamethasone—psoriasis	0.00574	0.00675	CbGbCtD
Chlorzoxazone—Digestion impaired—Methoxsalen—psoriasis	0.00405	0.037	CcSEcCtD
Chlorzoxazone—CYP2A6—CYP2E1 reactions—CYP2S1—psoriasis	0.00316	0.0771	CbGpPWpGaD
Chlorzoxazone—Lightheadedness—Beclomethasone—psoriasis	0.00309	0.0283	CcSEcCtD
Chlorzoxazone—Digestion impaired—Hydroxyurea—psoriasis	0.00252	0.023	CcSEcCtD
Chlorzoxazone—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.0025	0.0609	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Xenobiotics—CYP2S1—psoriasis	0.00196	0.0478	CbGpPWpGaD
Chlorzoxazone—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00177	0.0432	CbGpPWpGaD
Chlorzoxazone—Petechiae—Mycophenolic acid—psoriasis	0.00171	0.0157	CcSEcCtD
Chlorzoxazone—Digestion impaired—Cyclosporine—psoriasis	0.00171	0.0156	CcSEcCtD
Chlorzoxazone—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00165	0.0403	CbGpPWpGaD
Chlorzoxazone—Discomfort—Tazarotene—psoriasis	0.00165	0.0151	CcSEcCtD
Chlorzoxazone—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00155	0.0378	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Xenobiotics—CYP2S1—psoriasis	0.00146	0.0356	CbGpPWpGaD
Chlorzoxazone—Angioedema—Beclomethasone—psoriasis	0.00138	0.0126	CcSEcCtD
Chlorzoxazone—Rash—Calcipotriol—psoriasis	0.00137	0.0125	CcSEcCtD
Chlorzoxazone—Dermatitis—Calcipotriol—psoriasis	0.00137	0.0125	CcSEcCtD
Chlorzoxazone—Petechiae—Mycophenolate mofetil—psoriasis	0.00135	0.0124	CcSEcCtD
Chlorzoxazone—Drowsiness—Calcitriol—psoriasis	0.00135	0.0123	CcSEcCtD
Chlorzoxazone—Ecchymosis—Mycophenolic acid—psoriasis	0.00128	0.0117	CcSEcCtD
Chlorzoxazone—Petechiae—Prednisolone—psoriasis	0.00126	0.0115	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Beclomethasone—psoriasis	0.00123	0.0113	CcSEcCtD
Chlorzoxazone—Petechiae—Hydrocortisone—psoriasis	0.00123	0.0113	CcSEcCtD
Chlorzoxazone—Petechiae—Triamcinolone—psoriasis	0.00116	0.0106	CcSEcCtD
Chlorzoxazone—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.0011	0.0268	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Methoxsalen—psoriasis	0.0011	0.01	CcSEcCtD
Chlorzoxazone—KCNMA1—Nitric oxide stimulates guanylate cyclase—NOS2—psoriasis	0.00109	0.0266	CbGpPWpGaD
Chlorzoxazone—Malaise—Methoxsalen—psoriasis	0.00107	0.00974	CcSEcCtD
Chlorzoxazone—Petechiae—Betamethasone—psoriasis	0.00105	0.00962	CcSEcCtD
Chlorzoxazone—Petechiae—Dexamethasone—psoriasis	0.00105	0.00962	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Mycophenolic acid—psoriasis	0.00102	0.00936	CcSEcCtD
Chlorzoxazone—Rash—Tazarotene—psoriasis	0.00101	0.00921	CcSEcCtD
Chlorzoxazone—Dermatitis—Tazarotene—psoriasis	0.00101	0.0092	CcSEcCtD
Chlorzoxazone—Ecchymosis—Mycophenolate mofetil—psoriasis	0.00101	0.0092	CcSEcCtD
Chlorzoxazone—Discomfort—Methoxsalen—psoriasis	0.000995	0.00909	CcSEcCtD
Chlorzoxazone—Drowsiness—Hydroxyurea—psoriasis	0.000942	0.00861	CcSEcCtD
Chlorzoxazone—Ecchymosis—Prednisolone—psoriasis	0.000939	0.00858	CcSEcCtD
Chlorzoxazone—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000932	0.0227	CbGpPWpGaD
Chlorzoxazone—Petechiae—Prednisone—psoriasis	0.000917	0.00838	CcSEcCtD
Chlorzoxazone—Ecchymosis—Hydrocortisone—psoriasis	0.000917	0.00838	CcSEcCtD
Chlorzoxazone—Discomfort—Calcitriol—psoriasis	0.000887	0.0081	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Acitretin—psoriasis	0.00087	0.00795	CcSEcCtD
Chlorzoxazone—Ecchymosis—Triamcinolone—psoriasis	0.000863	0.00789	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Calcitriol—psoriasis	0.00086	0.00786	CcSEcCtD
Chlorzoxazone—Angioedema—Acitretin—psoriasis	0.000857	0.00783	CcSEcCtD
Chlorzoxazone—Rash—Clobetasol propionate—psoriasis	0.000855	0.00781	CcSEcCtD
Chlorzoxazone—Dermatitis—Clobetasol propionate—psoriasis	0.000854	0.0078	CcSEcCtD
Chlorzoxazone—Dyspepsia—Methoxsalen—psoriasis	0.00085	0.00776	CcSEcCtD
Chlorzoxazone—Malaise—Acitretin—psoriasis	0.000846	0.00773	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000833	0.00761	CcSEcCtD
Chlorzoxazone—Dizziness—Beclomethasone—psoriasis	0.000816	0.00746	CcSEcCtD
Chlorzoxazone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000814	0.0198	CbGpPWpGaD
Chlorzoxazone—Dizziness—Fluocinonide—psoriasis	0.000809	0.00739	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Mycophenolate mofetil—psoriasis	0.000808	0.00738	CcSEcCtD
Chlorzoxazone—CYP2A6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000804	0.0196	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—SERPINB8—psoriasis	0.000799	0.0195	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Methoxsalen—psoriasis	0.000795	0.00727	CcSEcCtD
Chlorzoxazone—Discomfort—Acitretin—psoriasis	0.000789	0.00721	CcSEcCtD
Chlorzoxazone—Ecchymosis—Betamethasone—psoriasis	0.000783	0.00716	CcSEcCtD
Chlorzoxazone—Ecchymosis—Dexamethasone—psoriasis	0.000783	0.00716	CcSEcCtD
Chlorzoxazone—Rash—Beclomethasone—psoriasis	0.000778	0.00711	CcSEcCtD
Chlorzoxazone—Dermatitis—Beclomethasone—psoriasis	0.000777	0.0071	CcSEcCtD
Chlorzoxazone—Rash—Fluocinonide—psoriasis	0.000771	0.00704	CcSEcCtD
Chlorzoxazone—Dermatitis—Fluocinonide—psoriasis	0.00077	0.00704	CcSEcCtD
Chlorzoxazone—Petechiae—Methotrexate—psoriasis	0.000766	0.007	CcSEcCtD
Chlorzoxazone—Somnolence—Calcitriol—psoriasis	0.000765	0.00699	CcSEcCtD
Chlorzoxazone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000719	0.0175	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Hydroxyurea—psoriasis	0.000683	0.00624	CcSEcCtD
Chlorzoxazone—Ecchymosis—Prednisone—psoriasis	0.000682	0.00623	CcSEcCtD
Chlorzoxazone—Somnolence—Acitretin—psoriasis	0.00068	0.00622	CcSEcCtD
Chlorzoxazone—Dyspepsia—Acitretin—psoriasis	0.000674	0.00616	CcSEcCtD
Chlorzoxazone—Malaise—Hydroxyurea—psoriasis	0.000664	0.00607	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Acitretin—psoriasis	0.000661	0.00604	CcSEcCtD
Chlorzoxazone—CYP2A6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00066	0.0161	CbGpPWpGaD
Chlorzoxazone—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000659	0.00602	CcSEcCtD
Chlorzoxazone—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000644	0.0157	CbGpPWpGaD
Chlorzoxazone—Dizziness—Methoxsalen—psoriasis	0.000638	0.00583	CcSEcCtD
Chlorzoxazone—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000635	0.0155	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Acitretin—psoriasis	0.000631	0.00576	CcSEcCtD
Chlorzoxazone—Discomfort—Hydroxyurea—psoriasis	0.000619	0.00566	CcSEcCtD
Chlorzoxazone—Rash—Methoxsalen—psoriasis	0.000609	0.00556	CcSEcCtD
Chlorzoxazone—Dermatitis—Methoxsalen—psoriasis	0.000608	0.00556	CcSEcCtD
Chlorzoxazone—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000607	0.0148	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000599	0.0146	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Mycophenolic acid—psoriasis	0.000572	0.00523	CcSEcCtD
Chlorzoxazone—Ecchymosis—Methotrexate—psoriasis	0.00057	0.00521	CcSEcCtD
Chlorzoxazone—Malaise—Mycophenolic acid—psoriasis	0.000556	0.00508	CcSEcCtD
Chlorzoxazone—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.000548	0.005	CcSEcCtD
Chlorzoxazone—Rash—Calcitriol—psoriasis	0.000542	0.00496	CcSEcCtD
Chlorzoxazone—Dermatitis—Calcitriol—psoriasis	0.000542	0.00495	CcSEcCtD
Chlorzoxazone—Somnolence—Hydroxyurea—psoriasis	0.000534	0.00488	CcSEcCtD
Chlorzoxazone—Dyspepsia—Hydroxyurea—psoriasis	0.000529	0.00483	CcSEcCtD
Chlorzoxazone—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000522	0.0127	CbGpPWpGaD
Chlorzoxazone—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000519	0.00474	CcSEcCtD
Chlorzoxazone—Discomfort—Mycophenolic acid—psoriasis	0.000519	0.00474	CcSEcCtD
Chlorzoxazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—psoriasis	0.00051	0.0124	CbGpPWpGaD
Chlorzoxazone—Dizziness—Acitretin—psoriasis	0.000506	0.00462	CcSEcCtD
Chlorzoxazone—Dizziness—Fluocinolone Acetonide—psoriasis	0.000505	0.00461	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Hydroxyurea—psoriasis	0.000495	0.00452	CcSEcCtD
Chlorzoxazone—CYP1A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000492	0.012	CbGpPWpGaD
Chlorzoxazone—Rash—Acitretin—psoriasis	0.000483	0.00441	CcSEcCtD
Chlorzoxazone—Dermatitis—Acitretin—psoriasis	0.000482	0.0044	CcSEcCtD
Chlorzoxazone—Rash—Fluocinolone Acetonide—psoriasis	0.000481	0.0044	CcSEcCtD
Chlorzoxazone—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000481	0.00439	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Cyclosporine—psoriasis	0.000463	0.00423	CcSEcCtD
Chlorzoxazone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000457	0.0111	CbGpPWpGaD
Chlorzoxazone—Angioedema—Cyclosporine—psoriasis	0.000456	0.00416	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Mycophenolate mofetil—psoriasis	0.000451	0.00413	CcSEcCtD
Chlorzoxazone—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000451	0.011	CbGpPWpGaD
Chlorzoxazone—Malaise—Cyclosporine—psoriasis	0.00045	0.00411	CcSEcCtD
Chlorzoxazone—Somnolence—Mycophenolic acid—psoriasis	0.000447	0.00409	CcSEcCtD
Chlorzoxazone—Angioedema—Mycophenolate mofetil—psoriasis	0.000445	0.00406	CcSEcCtD
Chlorzoxazone—Dyspepsia—Mycophenolic acid—psoriasis	0.000443	0.00405	CcSEcCtD
Chlorzoxazone—Malaise—Mycophenolate mofetil—psoriasis	0.000439	0.00401	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000434	0.00397	CcSEcCtD
Chlorzoxazone—KCNMA1—Platelet homeostasis—NOS2—psoriasis	0.000425	0.0104	CbGpPWpGaD
Chlorzoxazone—Ill-defined disorder—Prednisolone—psoriasis	0.000421	0.00385	CcSEcCtD
Chlorzoxazone—Discomfort—Cyclosporine—psoriasis	0.00042	0.00383	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisolone—psoriasis	0.000415	0.00379	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Mycophenolic acid—psoriasis	0.000415	0.00379	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Hydrocortisone—psoriasis	0.000411	0.00376	CcSEcCtD
Chlorzoxazone—Malaise—Prednisolone—psoriasis	0.000409	0.00374	CcSEcCtD
Chlorzoxazone—Discomfort—Mycophenolate mofetil—psoriasis	0.000409	0.00374	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Cyclosporine—psoriasis	0.000407	0.00372	CcSEcCtD
Chlorzoxazone—Angioedema—Hydrocortisone—psoriasis	0.000405	0.0037	CcSEcCtD
Chlorzoxazone—Malaise—Hydrocortisone—psoriasis	0.0004	0.00365	CcSEcCtD
Chlorzoxazone—Dizziness—Hydroxyurea—psoriasis	0.000397	0.00363	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000397	0.00363	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Triamcinolone—psoriasis	0.000387	0.00354	CcSEcCtD
Chlorzoxazone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000387	0.00943	CbGpPWpGaD
Chlorzoxazone—Discomfort—Prednisolone—psoriasis	0.000382	0.00349	CcSEcCtD
Chlorzoxazone—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000382	0.0093	CbGpPWpGaD
Chlorzoxazone—Angioedema—Triamcinolone—psoriasis	0.000381	0.00349	CcSEcCtD
Chlorzoxazone—Rash—Hydroxyurea—psoriasis	0.000379	0.00346	CcSEcCtD
Chlorzoxazone—Dermatitis—Hydroxyurea—psoriasis	0.000378	0.00346	CcSEcCtD
Chlorzoxazone—Malaise—Triamcinolone—psoriasis	0.000376	0.00344	CcSEcCtD
Chlorzoxazone—Discomfort—Hydrocortisone—psoriasis	0.000373	0.00341	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Prednisolone—psoriasis	0.00037	0.00338	CcSEcCtD
Chlorzoxazone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00037	0.00902	CbGpPWpGaD
Chlorzoxazone—Somnolence—Cyclosporine—psoriasis	0.000362	0.00331	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Hydrocortisone—psoriasis	0.000362	0.00331	CcSEcCtD
Chlorzoxazone—Dyspepsia—Cyclosporine—psoriasis	0.000358	0.00327	CcSEcCtD
Chlorzoxazone—Somnolence—Mycophenolate mofetil—psoriasis	0.000353	0.00323	CcSEcCtD
Chlorzoxazone—Drowsiness—Methotrexate—psoriasis	0.000353	0.00322	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000351	0.00321	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Betamethasone—psoriasis	0.000351	0.00321	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Dexamethasone—psoriasis	0.000351	0.00321	CcSEcCtD
Chlorzoxazone—Discomfort—Triamcinolone—psoriasis	0.000351	0.00321	CcSEcCtD
Chlorzoxazone—CYP2A6—Biological oxidations—CYP2S1—psoriasis	0.000351	0.00855	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00035	0.00319	CcSEcCtD
Chlorzoxazone—Angioedema—Dexamethasone—psoriasis	0.000346	0.00316	CcSEcCtD
Chlorzoxazone—Angioedema—Betamethasone—psoriasis	0.000346	0.00316	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000343	0.00313	CcSEcCtD
Chlorzoxazone—Malaise—Dexamethasone—psoriasis	0.000342	0.00312	CcSEcCtD
Chlorzoxazone—Malaise—Betamethasone—psoriasis	0.000342	0.00312	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Triamcinolone—psoriasis	0.000341	0.00311	CcSEcCtD
Chlorzoxazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—psoriasis	0.000338	0.00824	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Cyclosporine—psoriasis	0.000335	0.00307	CcSEcCtD
Chlorzoxazone—Dizziness—Mycophenolic acid—psoriasis	0.000333	0.00304	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000327	0.00299	CcSEcCtD
Chlorzoxazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—psoriasis	0.000325	0.00793	CbGpPWpGaD
Chlorzoxazone—Discomfort—Betamethasone—psoriasis	0.000319	0.00291	CcSEcCtD
Chlorzoxazone—Discomfort—Dexamethasone—psoriasis	0.000319	0.00291	CcSEcCtD
Chlorzoxazone—Dyspepsia—Hydrocortisone—psoriasis	0.000318	0.00291	CcSEcCtD
Chlorzoxazone—CYP1A1—Oxidative Stress—CAT—psoriasis	0.000317	0.00773	CbGpPWpGaD
Chlorzoxazone—Rash—Mycophenolic acid—psoriasis	0.000317	0.0029	CcSEcCtD
Chlorzoxazone—Dermatitis—Mycophenolic acid—psoriasis	0.000317	0.0029	CcSEcCtD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000314	0.00764	CbGpPWpGaD
Chlorzoxazone—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000312	0.00285	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Dexamethasone—psoriasis	0.000309	0.00282	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Betamethasone—psoriasis	0.000309	0.00282	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Prednisone—psoriasis	0.000306	0.0028	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Prednisolone—psoriasis	0.000305	0.00279	CcSEcCtD
Chlorzoxazone—Angioedema—Prednisone—psoriasis	0.000301	0.00275	CcSEcCtD
Chlorzoxazone—Dyspepsia—Triamcinolone—psoriasis	0.0003	0.00274	CcSEcCtD
Chlorzoxazone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000299	0.00728	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Hydrocortisone—psoriasis	0.000298	0.00272	CcSEcCtD
Chlorzoxazone—Malaise—Prednisone—psoriasis	0.000297	0.00272	CcSEcCtD
Chlorzoxazone—CYP1A1—Estrogen Receptor Pathway—JUN—psoriasis	0.000297	0.00725	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000296	0.0072	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—psoriasis	0.000295	0.0072	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000295	0.00718	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000291	0.00709	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Triamcinolone—psoriasis	0.000281	0.00257	CcSEcCtD
Chlorzoxazone—Discomfort—Prednisone—psoriasis	0.000277	0.00254	CcSEcCtD
Chlorzoxazone—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.000277	0.00675	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000273	0.00666	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Betamethasone—psoriasis	0.000272	0.00249	CcSEcCtD
Chlorzoxazone—Dyspepsia—Dexamethasone—psoriasis	0.000272	0.00249	CcSEcCtD
Chlorzoxazone—Dizziness—Cyclosporine—psoriasis	0.000269	0.00246	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Prednisone—psoriasis	0.000269	0.00246	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Betamethasone—psoriasis	0.000267	0.00244	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000267	0.00244	CcSEcCtD
Chlorzoxazone—Dizziness—Mycophenolate mofetil—psoriasis	0.000263	0.0024	CcSEcCtD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP2S1—psoriasis	0.000261	0.00637	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000258	0.00628	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Estrogen Receptor Pathway—STAT3—psoriasis	0.000257	0.00627	CbGpPWpGaD
Chlorzoxazone—Rash—Cyclosporine—psoriasis	0.000257	0.00235	CcSEcCtD
Chlorzoxazone—Dermatitis—Cyclosporine—psoriasis	0.000256	0.00234	CcSEcCtD
Chlorzoxazone—Ill-defined disorder—Methotrexate—psoriasis	0.000256	0.00234	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Dexamethasone—psoriasis	0.000255	0.00233	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Betamethasone—psoriasis	0.000255	0.00233	CcSEcCtD
Chlorzoxazone—CYP1A1—Melatonin metabolism and effects—APOE—psoriasis	0.000253	0.00617	CbGpPWpGaD
Chlorzoxazone—Rash—Mycophenolate mofetil—psoriasis	0.00025	0.00229	CcSEcCtD
Chlorzoxazone—Dermatitis—Mycophenolate mofetil—psoriasis	0.00025	0.00229	CcSEcCtD
Chlorzoxazone—Malaise—Methotrexate—psoriasis	0.000249	0.00227	CcSEcCtD
Chlorzoxazone—Dizziness—Prednisolone—psoriasis	0.000245	0.00224	CcSEcCtD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000242	0.0059	CbGpPWpGaD
Chlorzoxazone—Dizziness—Hydrocortisone—psoriasis	0.000239	0.00219	CcSEcCtD
Chlorzoxazone—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000239	0.00583	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000239	0.00582	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Prednisone—psoriasis	0.000237	0.00217	CcSEcCtD
Chlorzoxazone—Rash—Prednisolone—psoriasis	0.000234	0.00213	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisolone—psoriasis	0.000233	0.00213	CcSEcCtD
Chlorzoxazone—KCNMA1—Hemostasis—ITGAL—psoriasis	0.000232	0.00566	CbGpPWpGaD
Chlorzoxazone—Discomfort—Methotrexate—psoriasis	0.000232	0.00212	CcSEcCtD
Chlorzoxazone—Rash—Hydrocortisone—psoriasis	0.000228	0.00208	CcSEcCtD
Chlorzoxazone—Dermatitis—Hydrocortisone—psoriasis	0.000228	0.00208	CcSEcCtD
Chlorzoxazone—CYP1A1—Tryptophan metabolism—CAT—psoriasis	0.000225	0.00549	CbGpPWpGaD
Chlorzoxazone—Dizziness—Triamcinolone—psoriasis	0.000225	0.00206	CcSEcCtD
Chlorzoxazone—Anaphylactic shock—Methotrexate—psoriasis	0.000225	0.00206	CcSEcCtD
Chlorzoxazone—Feeling abnormal—Prednisone—psoriasis	0.000222	0.00203	CcSEcCtD
Chlorzoxazone—Rash—Triamcinolone—psoriasis	0.000215	0.00196	CcSEcCtD
Chlorzoxazone—Dermatitis—Triamcinolone—psoriasis	0.000215	0.00196	CcSEcCtD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—LEP—psoriasis	0.000214	0.00521	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000206	0.00502	CbGpPWpGaD
Chlorzoxazone—Dizziness—Betamethasone—psoriasis	0.000204	0.00187	CcSEcCtD
Chlorzoxazone—Dizziness—Dexamethasone—psoriasis	0.000204	0.00187	CcSEcCtD
Chlorzoxazone—Somnolence—Methotrexate—psoriasis	0.0002	0.00183	CcSEcCtD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—NOS2—psoriasis	0.000199	0.00486	CbGpPWpGaD
Chlorzoxazone—Dyspepsia—Methotrexate—psoriasis	0.000198	0.00181	CcSEcCtD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000197	0.00479	CbGpPWpGaD
Chlorzoxazone—CYP2A6—NRF2 pathway—TGFA—psoriasis	0.000195	0.00476	CbGpPWpGaD
Chlorzoxazone—Rash—Dexamethasone—psoriasis	0.000195	0.00178	CcSEcCtD
Chlorzoxazone—Rash—Betamethasone—psoriasis	0.000195	0.00178	CcSEcCtD
Chlorzoxazone—Dermatitis—Dexamethasone—psoriasis	0.000195	0.00178	CcSEcCtD
Chlorzoxazone—Dermatitis—Betamethasone—psoriasis	0.000195	0.00178	CcSEcCtD
Chlorzoxazone—Gastrointestinal disorder—Methotrexate—psoriasis	0.000194	0.00177	CcSEcCtD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000194	0.00473	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000191	0.00465	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.00019	0.00462	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—PPARG—psoriasis	0.000186	0.00454	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000186	0.00452	CbGpPWpGaD
Chlorzoxazone—Feeling abnormal—Methotrexate—psoriasis	0.000185	0.00169	CcSEcCtD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—CARM1—psoriasis	0.000182	0.00445	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000179	0.00435	CbGpPWpGaD
Chlorzoxazone—Dizziness—Prednisone—psoriasis	0.000178	0.00163	CcSEcCtD
Chlorzoxazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000178	0.00433	CbGpPWpGaD
Chlorzoxazone—Rash—Prednisone—psoriasis	0.00017	0.00155	CcSEcCtD
Chlorzoxazone—Dermatitis—Prednisone—psoriasis	0.00017	0.00155	CcSEcCtD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000167	0.00406	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000164	0.004	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000164	0.004	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000162	0.00394	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Melatonin metabolism and effects—NFKB1—psoriasis	0.000151	0.00367	CbGpPWpGaD
Chlorzoxazone—Dizziness—Methotrexate—psoriasis	0.000149	0.00136	CcSEcCtD
Chlorzoxazone—CYP1A1—Oxidative Stress—NFKB1—psoriasis	0.000147	0.00357	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000144	0.0035	CbGpPWpGaD
Chlorzoxazone—Rash—Methotrexate—psoriasis	0.000142	0.0013	CcSEcCtD
Chlorzoxazone—Dermatitis—Methotrexate—psoriasis	0.000142	0.00129	CcSEcCtD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000137	0.00334	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—JUN—psoriasis	0.000132	0.00322	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000129	0.00313	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000127	0.00309	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000125	0.00305	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	0.000125	0.00305	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000124	0.00302	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.000123	0.003	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000113	0.00276	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000111	0.0027	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.000108	0.00264	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	0.000104	0.00254	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	9.61e-05	0.00234	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.56e-05	0.00233	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—NOS2—psoriasis	9.53e-05	0.00232	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	9.45e-05	0.0023	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—TP53—psoriasis	8.73e-05	0.00213	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	8.1e-05	0.00197	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	8.1e-05	0.00197	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—IL6—psoriasis	7.99e-05	0.00195	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.98e-05	0.00195	CbGpPWpGaD
Chlorzoxazone—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	7.59e-05	0.00185	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	7.43e-05	0.00181	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NDUFA5—psoriasis	7.05e-05	0.00172	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.9e-05	0.00168	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.64e-05	0.00162	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	6.03e-05	0.00147	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP2S1—psoriasis	6e-05	0.00146	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NDUFA5—psoriasis	5.57e-05	0.00136	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—VEGFA—psoriasis	5.52e-05	0.00134	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NDUFA5—psoriasis	5.25e-05	0.00128	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.17e-05	0.00126	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.17e-05	0.00126	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	5.12e-05	0.00125	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.9e-05	0.00119	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP2S1—psoriasis	4.74e-05	0.00115	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP2S1—psoriasis	4.47e-05	0.00109	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Hemostasis—TP53—psoriasis	4.17e-05	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NDUFA5—psoriasis	3.95e-05	0.000964	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2S1—psoriasis	3.36e-05	0.00082	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NDUFA5—psoriasis	3.35e-05	0.000817	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.12e-05	0.000761	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CARM1—psoriasis	2.93e-05	0.000714	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2S1—psoriasis	2.85e-05	0.000694	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NDUFA5—psoriasis	2.59e-05	0.00063	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.34e-05	0.000571	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CARM1—psoriasis	2.31e-05	0.000564	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2S1—psoriasis	2.2e-05	0.000536	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CARM1—psoriasis	2.18e-05	0.000532	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.04e-05	0.000497	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CAT—psoriasis	1.8e-05	0.000439	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CARM1—psoriasis	1.64e-05	0.0004	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.49e-05	0.000364	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CAT—psoriasis	1.42e-05	0.000347	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOE—psoriasis	1.4e-05	0.000341	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CARM1—psoriasis	1.39e-05	0.000339	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CAT—psoriasis	1.34e-05	0.000327	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.3e-05	0.000317	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PPARG—psoriasis	1.22e-05	0.000297	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOE—psoriasis	1.11e-05	0.00027	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CARM1—psoriasis	1.07e-05	0.000262	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOE—psoriasis	1.04e-05	0.000254	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CAT—psoriasis	1.01e-05	0.000246	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PPARG—psoriasis	9.63e-06	0.000235	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PPARG—psoriasis	9.08e-06	0.000221	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CAT—psoriasis	8.56e-06	0.000209	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOE—psoriasis	7.85e-06	0.000191	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PPARG—psoriasis	6.84e-06	0.000167	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOE—psoriasis	6.65e-06	0.000162	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CAT—psoriasis	6.6e-06	0.000161	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PPARG—psoriasis	5.79e-06	0.000141	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOE—psoriasis	5.13e-06	0.000125	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PPARG—psoriasis	4.47e-06	0.000109	CbGpPWpGaD
